{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:49:15Z","timestamp":1792172955743,"version":"4.4.0"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,5,7]],"date-time":"2021-05-07T00:00:00Z","timestamp":1620345600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease with no therapeutic consensus. Oxidation and inflammation are hallmarks in the progression of this complex disease, which also involves interactions between the genetic background and the environment. Mastiha is a natural nutritional supplement known to possess antioxidant and anti-inflammatory properties. This study investigated how a 6-month Mastiha supplementation (2.1 g\/day) could impact the antioxidant and inflammatory status of patients with NAFLD, and whether genetic variants significantly mediate these effects. We recruited 98 patients with obesity (BMI \u2265 30 kg\/m<jats:sup>2<\/jats:sup>) and NAFLD and randomly allocated them to either the Mastiha or the placebo group for 6 months. The anti-oxidative and inflammatory status was assessed at baseline and post-treatment. Genome-wide genetic data was also obtained from all participants, to investigate gene-by-Mastiha interactions. NAFLD patients with severe obesity (BMI &amp;gt; 35kg\/m<jats:sup>2<\/jats:sup>) taking the Mastiha had significantly higher total antioxidant status (TAS) compared to the corresponding placebo group (P value=0.008). We did not observe any other significant change in the investigated biomarkers as a result of Mastiha supplementation alone. We identified several novel gene-by-Mastiha interaction associations with levels of cytokines and antioxidant biomarkers. Some of the identified genetic loci are implicated in the pathological pathways of NAFLD, including the lanosterol synthase gene (<jats:italic>LSS)<\/jats:italic> associated with glutathione peroxidase activity (Gpx) levels, the mitochondrial pyruvate carrier-1 gene (<jats:italic>MPC1)<\/jats:italic> and the sphingolipid transporter-1 gene (<jats:italic>SPNS1<\/jats:italic>) associated with hemoglobin levels, the transforming growth factor\u2010beta\u2010induced gene (<jats:italic>TGFBI<\/jats:italic>) and the micro-RNA 129-1 (<jats:italic>MIR129-1)<\/jats:italic> associated with IL-6 and the granzyme B gene (<jats:italic>GZMB<\/jats:italic>) associated with IL-10 levels. Within the MAST4HEALTH randomized clinical trial (NCT03135873, <jats:uri>www.clinicaltrials.gov<\/jats:uri>) Mastiha supplementation improved the TAS levels among NAFLD patients with severe obesity. We identified several novel genome-wide significant nutrigenetic interactions, influencing the antioxidant and inflammatory status in NAFLD.<\/jats:p><jats:sec><jats:title>Clinical Trial Registration<\/jats:title><jats:p><jats:uri>ClinicalTrials.gov<\/jats:uri>, identifier NCT03135873.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2021.683028","type":"journal-article","created":{"date-parts":[[2021,5,7]],"date-time":"2021-05-07T11:05:28Z","timestamp":1620385528000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":29,"title":["Nutrigenetic Interactions Might Modulate the Antioxidant and Anti-Inflammatory Status in Mastiha-Supplemented Patients With NAFLD"],"prefix":"10.3389","volume":"12","author":[{"given":"Stavroula","family":"Kanoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satish","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charalampia","family":"Amerikanou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Jo","family":"Kurth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria G.","family":"Stathopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephane","family":"Bourgeois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Masson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimo","family":"Kannt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Cesarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Spyridoula","family":"Kontoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Milanovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco J.","family":"Roig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjana","family":"Beribaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonica","family":"Campolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Jim\u00e9nez-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nata\u0161a","family":"Milo\u0161evi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Llorens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilias","family":"Smyrnioudis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Pilar","family":"Francino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nata\u0161a","family":"Mili\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andriana C.","family":"Kaliora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Giovanna","family":"Trivella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark W.","family":"Ruddock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milica","family":"Medi\u0107-Stojanoska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amalia","family":"Gastaldelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Lamont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panos","family":"Deloukas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George V.","family":"Dedoussis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Visvikis-Siest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,5,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gtc.2016.07.003","article-title":"Nonalcoholic Fatty Liver Disease: Pathophysiology and Management","volume":"45","author":"Carr","year":"2016","journal-title":"Gastroenterol Clin North Am"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD Development and Therapeutic Strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i48.18070","article-title":"Adipokines and Proinflammatory Cytokines, the Key Mediators in the Pathogenesis of Nonalcoholic Fatty Liver Disease","volume":"20","author":"Stojsavljevic","year":"2014","journal-title":"World J Gastroenterol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e1003100","DOI":"10.1371\/journal.pmed.1003100","article-title":"Metabolic Risk Factors and Incident Advanced Liver Disease in Non-Alcoholic Fatty Liver Disease (NAFLD): A Systematic Review and Meta-Analysis of Population-Based Observational Studies","volume":"17","author":"Jarvis","year":"2020","journal-title":"PloS Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41423-020-00579-3","article-title":"Immunological Mechanisms and Therapeutic Targets of Fatty Liver Diseases","volume":"18","author":"Wang","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1530\/JOE-13-0201","article-title":"Inflammation as a Potential Link Between Nonalcoholic Fatty Liver Disease and Insulin Resistance","volume":"218","author":"Asrih","year":"2013","journal-title":"J Endocrinol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"436","DOI":"10.3390\/ijms22010436","article-title":"Immunity as Cornerstone of Non-Alcoholic Fatty Liver Disease: The Contribution of Oxidative Stress in the Disease Progression","volume":"22","author":"Dallio","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"European Association for the Study of and O. European Association for the Study of: EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease","volume":"64","year":"2016","journal-title":"J Hepatol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/nutrit\/nuz029","article-title":"Effect of Dietary Intervention, With or Without Co-Interventions, on Inflammatory Markers in Patients With Nonalcoholic Fatty Liver Disease: A Systematic Literature Review","volume":"77","author":"Reddy","year":"2019","journal-title":"Nutr Rev"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2017.12.020","article-title":"Medicinal Plants and Bioactive Natural Compounds in the Treatment of Non-Alcoholic Fatty Liver Disease: A Clinical Review","volume":"130","author":"Bagherniya","year":"2018","journal-title":"Pharmacol Res"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v22.i30.6890","article-title":"Herbal Medicines and Nonalcoholic Fatty Liver Disease","volume":"22","author":"Yao","year":"2016","journal-title":"World J Gastroenterol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2019.112485","article-title":"Traditional Uses, Phytochemistry and Pharmacology of Chios Mastic Gum (Pistacia Lentiscus Var","volume":"254","author":"Pachi","year":"2020","journal-title":"Chia Anacardiaceae): A Rev J Ethnopharmacol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3390\/antiox8070208","article-title":"Antioxidant and Anti-Inflammatory Properties of Mastiha: A Review of Preclinical and Clinical Studies","volume":"8","author":"Papada","year":"2019","journal-title":"Antioxid (Basel)"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e1900927","DOI":"10.1002\/mnfr.201900927","article-title":"Mastiha (Pistacia Lentiscus) Improves Gut Microbiota Diversity, Hepatic Steatosis, and Disease Activity in a Biopsy-Confirmed Mouse Model of Advanced Non-Alcoholic Steatohepatitis and Fibrosis","volume":"63","author":"Kannt","year":"2019","journal-title":"Mol Nutr Food Res"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2986","DOI":"10.3390\/ijms21082986","article-title":"Nutrition and Genetics in NAFLD: The Perfect Binomium","volume":"21","author":"Meroni","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1053\/j.gastro.2010.07.057","article-title":"Genome-Wide Association Study Identifies Variants Associated With Histologic Features of Nonalcoholic Fatty Liver Disease","volume":"139","author":"Chalasani","year":"2010","journal-title":"Gastroenterology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e1001324","DOI":"10.1371\/journal.pgen.1001324","article-title":"Genome-Wide Association Analysis Identifies Variants Associated With Nonalcoholic Fatty Liver Disease That Have Distinct Effects on Metabolic Traits","volume":"7","author":"Speliotes","year":"2011","journal-title":"PloS Genet"},{"key":"B18","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12916-019-1364-z","article-title":"GWAS and Enrichment Analyses of Non-Alcoholic Fatty Liver Disease Identify New Trait-Associated Genes and Pathways Across Emerge Network","volume":"17","author":"Namjou","year":"2019","journal-title":"BMC Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.04.003","article-title":"Genome-Wide Association Study of Non-Alcoholic Fatty Liver and Steatohepatitis in a Histologically Characterised Cohort()","volume":"73","author":"Anstee","year":"2020","journal-title":"J Hepatol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.3390\/ijms18071534","article-title":"A Nutrigenomic Approach to Non-Alcoholic Fatty Liver Disease","volume":"18","author":"Dongiovanni","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s12263-013-0383-1","article-title":"A Case-Control Study on the Effect of Metabolic Gene Polymorphisms, Nutrition, and Their Interaction on the Risk of Non-Alcoholic Fatty Liver Disease","volume":"9","author":"Miele","year":"2014","journal-title":"Genes Nutr"},{"key":"B22","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jnutbio.2015.10.001","article-title":"Microrna Changes, Activation of Progenitor Cells and Severity of Liver Injury in Mice Induced by Choline and Folate Deficiency","volume":"28","author":"Tryndyak","year":"2016","journal-title":"J Nutr Biochem"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e2001178","DOI":"10.1002\/mnfr.202001178","article-title":"Effect of Mastiha Supplementation on NAFLD: The MAST4HEALTH Randomised, Controlled Trial","volume":"10","author":"Amerikanou","year":"2021","journal-title":"Mol Nutr Food Res"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13284","article-title":"Multiparametric Magnetic Resonance Imaging for the Assessment of Non-Alcoholic Fatty Liver Disease Severity","volume":"37","author":"Pavlides","year":"2017","journal-title":"Liver Int"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1249\/01.MSS.0000078924.61453.FB","article-title":"International Physical Activity Questionnaire: 12-Country Reliability and Validity","volume":"35","author":"Craig","year":"2003","journal-title":"Med Sci Sports Exerc"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3656","article-title":"Next-Generation Genotype Imputation Service and Methods","volume":"48","author":"Das","year":"2016","journal-title":"Nat Genet"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/gepi.21748","article-title":"Finding Novel Genes by Testing G X E Interactions in a Genome-Wide Association Study","volume":"37","author":"Gauderman","year":"2013","journal-title":"Genet Epidemiol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.4274\/Jcrpe.825","article-title":"Association Between Insulin Resistance and Oxidative Stress Parameters in Obese Adolescents With Non-Alcoholic Fatty Liver Disease","volume":"5","author":"Pirgon","year":"2013","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01802","article-title":"Chemokines in Non-Alcoholic Fatty Liver Disease: A Systematic Review and Network Meta-Analysis","volume":"11","author":"Pan","year":"2020","journal-title":"Front Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1089\/jir.2008.0027","article-title":"Monocyte Chemoattractant Protein-1 (MCP-1): An Overview","volume":"29","author":"Deshmane","year":"2009","journal-title":"J Interferon Cytokine Res"},{"key":"B31","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.3390\/ijms20143458","article-title":"Effect of Different Classes of Antihypertensive Drugs on Endothelial Function and Inflammation","volume":"20","author":"Silva","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.3390\/molecules25092224","article-title":"Anti-Inflammatory Strategies Targeting Metaflammation in Type 2 Diabetes","volume":"25","author":"Kurylowicz","year":"2020","journal-title":"Molecules"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1995.2110","article-title":"Molecular Cloning of the Human Gene Encoding Lanosterol Synthase From a Liver Cdna Library","volume":"213","author":"Baker","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2010.05.037","article-title":"Cholesterol Synthesis is Increased and Absorption Decreased in Non-Alcoholic Fatty Liver Disease Independent of Obesity","volume":"54","author":"Simonen","year":"2011","journal-title":"J\u00a0Hepatol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e1292","DOI":"10.7717\/peerj.1292","article-title":"Investigation Into the Effects of Antioxidant-Rich Extract of Tamarindus Indica Leaf on Antioxidant Enzyme Activities, Oxidative Stress and Gene Expression Profiles in Hepg2 Cells","volume":"3","author":"Razali","year":"2015","journal-title":"PeerJ"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3737","article-title":"Identification of Context-Dependent Expression Quantitative Trait Loci in Whole Blood","volume":"49","author":"Zhernakova","year":"2017","journal-title":"Nat Genet"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.5604\/01.3001.0012.0920","article-title":"Association Between Serum Hemoglobin Levels and Non Alcoholic Fatty Liver Disease in a Mexican Population","volume":"17","author":"Juarez-Hernandez","year":"2018","journal-title":"Ann Hepatol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3109\/00365521.2014.983160","article-title":"Characterization of Lean Patients With Nonalcoholic Fatty Liver Disease: Potential Role of High Hemoglobin Levels","volume":"50","author":"Akyuz","year":"2015","journal-title":"Scand J Gastroenterol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"447367","DOI":"10.1101\/447367","article-title":"Unraveling the Polygenic Architecture of Complex Traits Using Blood Eqtl Metaanalysis","author":"V\u00f5sa","year":"2018","journal-title":"bioRxiv"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2756","article-title":"Systematic Identification of Trans Eqtls as Putative Drivers of Known Disease Associations","volume":"45","author":"Westra","year":"2013","journal-title":"Nat Genet"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.3390\/biom10081162","article-title":"Mitochondrial Pyruvate Carrier Function in Health and Disease Across the Lifespan","volume":"10","author":"Buchanan","year":"2020","journal-title":"Biomolecules"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2017.09.002","article-title":"The Mitochondrial Pyruvate Carrier Mediates High Fat Diet-Induced Increases in Hepatic TCA Cycle Capacity","volume":"6","author":"Rauckhorst","year":"2017","journal-title":"Mol Metab"},{"key":"B43","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3390\/ijms21010040","article-title":"Sphingolipids in Non-Alcoholic Fatty Liver Disease and Hepatocellular Carcinoma: Ceramide Turnover","volume":"21","author":"Simon","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1126\/science.1262110","article-title":"Human Genomics. the Genotype-Tissue Expression (Gtex) Pilot Analysis: Multitissue Gene Regulation in Humans","volume":"348","year":"2015","journal-title":"Science"},{"key":"B45","doi-asserted-by":"publisher","first-page":"e8793","DOI":"10.15252\/msb.20188793","article-title":"Plasma Proteome Profiling Discovers Novel Proteins Associated With Non-Alcoholic Fatty Liver Disease","volume":"15","author":"Niu","year":"2019","journal-title":"Mol Syst Biol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/s0092-8674(04)00045-5","article-title":"Micrornas: Genomics, Biogenesis, Mechanism, and Function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"B47","doi-asserted-by":"publisher","first-page":"3966","DOI":"10.3390\/ijms19123966","article-title":"Mirna Signature in NAFLD: A Turning Point for a Non-Invasive Diagnosis","volume":"19","author":"Dongiovanni","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2014-306996","article-title":"Circulating Microrna Signature in Non-Alcoholic Fatty Liver Disease: From Serum Non-Coding Rnas to Liver Histology and Disease Pathogenesis","volume":"64","author":"Pirola","year":"2015","journal-title":"Gut"},{"key":"B49","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1186\/s12967-020-02577-5","article-title":"Lncrna NEAT1\/Microrna-129-5p\/SOCS2 Axis Regulates Liver Fibrosis in Alcoholic Steatohepatitis","volume":"18","author":"Ye","year":"2020","journal-title":"J Transl Med"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.3389\/fgene.2020.563265","article-title":"Downregulated Microrna-129-5p by Long Non-Coding RNA NEAT1 Upregulates PEG3 Expression to Aggravate Non-Alcoholic Steatohepatitis","volume":"11","author":"Zhang","year":"2021","journal-title":"Front Genet"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2016.10.011","article-title":"Leptin in Inflammation and Autoimmunity","volume":"98","author":"La Cava","year":"2017","journal-title":"Cytokine"},{"key":"B52","doi-asserted-by":"publisher","first-page":"392","DOI":"10.3350\/cmh.2018.0011","article-title":"The Association of Leptin With Severity of Non-Alcoholic Fatty Liver Disease: A Population-Based Study","volume":"24","author":"Rotundo","year":"2018","journal-title":"Clin Mol Hepatol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2020.109804","article-title":"Granzymes in Cardiovascular Injury and Disease","volume":"76","author":"Zeglinski","year":"2020","journal-title":"Cell Signal"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00040.2019","article-title":"CD8(+) T Cells Regulate Liver Injury in Obesity-Related Nonalcoholic Fatty Liver Disease","volume":"318","author":"Breuer","year":"2020","journal-title":"Am J Physiol Gastrointest Liver Physiol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.683028\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,7]],"date-time":"2021-05-07T11:05:31Z","timestamp":1620385531000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.683028\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,7]]},"references-count":54,"alternative-id":["10.3389\/fimmu.2021.683028"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.683028","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,7]]},"article-number":"683028"}}